Darvias IV infusion 135mg

Darvias IV infusion 135mg, manufactured by Solasia Pharma, contains Darinaparsin. This organic arsenical compound disrupts mitochondrial function, increases reactive oxygen species, and modulates signal transduction pathways, leading to cell cycle arrest and apoptosis in cancer cells. It is supplied as 135mg per bottle, with YJ code 4291462D1022.